Acer Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Acer Therapeutics

16/05/2022 22:26

* Acer Therapeutics Inc  ACER.OQ  reported a quarterly
adjusted
loss of 64 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 41 cents per share.
    * Reported revenue was zero​;  analysts expected $2.50
million. 
    * Acer Therapeutics Inc's reported EPS for the quarter was a
loss
of 64 cents​.
    * The mean earnings estimate of analysts had fallen by
about 453.3% in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Acer Therapeutics Inc shares had fallen by 33.1% this
quarter and lost 14.9% so far this year.
    * The company reported a quarterly loss of $9.18 million.
    * Wall Street's median 12-month price target for Acer
Therapeutics
Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 09:26 p.m.  ​All
figures in US dollars unless otherwise stated